The global colostrum market size was estimated at USD 3,362.7 million in 2023 and is expected to grow at a CAGR of 7.2% from 2024 to 2030. There’s a rising interest in natural health solutions and alternative medicine among consumers. Colostrum aligns well with this trend, being a natural substance with a long history of traditional use for its purported health benefits. As people seek ways to support their immune systems and overall well-being, colostrum emerges as an attractive option due to its potential to enhance immune function, support gut health, and aid in tissue repair. Colostrum’s unique composition also offers significant benefits for sports nutrition regimens.
It provides essential growth factors aiding cellular growth and repair, which is particularly crucial for maintaining intestinal barrier integrity post-intensive training sessions. In addition, colostrum contains immunoglobulins that support the immune system during athletic training. Immune factors like lactoferrin, lysozyme, and lactoperoxidase possess antimicrobial properties, supporting the immune system against the physiological stress of physical training. Moreover, colostrum's complex oligosaccharides nourish beneficial gut bacteria and improve the gut microbiome, which rigorous training can negatively impact. Owing to such factors, there is a growing adoption of colostrum among athletes and consumers who take part in regular intensive training.
The colostrum market exhibits a moderate to high degree of innovation, driven by advancements in research, technology, and consumer demand for natural health products. Colostrum, the first milk produced by mammals after giving birth, contains a rich array of bioactive compounds that confer numerous health benefits. Traditionally used for its immune-boosting properties, colostrum is now being explored for its potential in sports nutrition, skincare, and veterinary applications.
Innovations in colostrum processing techniques have led to the development of more potent and bioavailable products, such as colostrum powders, capsules, and topical formulations. These advancements aim to preserve the integrity of bioactive components while enhancing their absorption and efficacy. Additionally, research into colostrum's specific bioactive molecules, such as growth factors, immunoglobulins, and lactoferrin, has paved the way for targeted therapeutic applications in gut health, wound healing, and anti-aging.
The level of M&A activities in the colostrum industry is currently moderate. As technology matures and market demand grows, companies increasingly explore strategic partnerships, acquisitions, and collaborations to enhance their capabilities, expand their product offerings, and gain a competitive edge.
The conventional segment accounted for a dominant share of 79.73% of the global revenue in 2023. Conventional colostrum is derived from cows raised using traditional farming methods, which may include the use of synthetic pesticides, hormones, and antibiotics in farming practices. Conventional colostrum-based products cater to consumers looking for more affordable options without emphasizing organic or sustainable farming practices. These products are still rich in essential nutrients and bioactive compounds, making them a viable choice for those seeking the benefits of colostrum at a lower price point.
The organic segment is anticipated to register the fastest CAGR of 8.1% from 2024 to 2030. The demand for organic colostrum products has increased due to a growing awareness of the health benefits of organic, pasture-fed dairy products. Organic colostrum is prized for its rich nutritional profile, including immune-boosting components and growth factors, making it a sought-after supplement for immune support, gut health, and overall well-being. Nourish Naturals Products offers organic colostrum capsules sourced from ethically raised cows on organic farms. These capsules support immune health, gut function, and overall well-being.
The B2C distribution channel segment accounted for the largest revenue share of 88.64% in 2023. The presence of colostrum products in hypermarkets and supermarkets increases visibility and accessibility for a wide consumer base, leading to higher sales. Colostrum products in convenient formats like single-dose sachets or ready-to-drink options appeal to busy consumers who frequent convenience stores, increasing sales.
The B2B channel segment is projected to grow at a CAGR of 6.3% from 2024 to 2030. Colostrum's versatile bioactive properties drive its demand in B2B end use applications. Leading colostrum suppliers and manufacturers meet this demand by providing high-quality colostrum-based ingredients, formulations, and products to businesses across various industries, fueling innovation and growth in the global colostrum market.
The cow colostrum segment held the highest revenue share of 88.04% in 2023. Cow colostrum is gaining popularity compared to other sources due to several key benefits, such as its rich nutritional profile, bioavailability, absorption, immune-boosting properties, and gentleness on the digestive system. Cow colostrum is filled with essential nutrients, growth factors, antibodies, and immune-boosting compounds, making it a comprehensive source of health-promoting substances. This nutrient density sets cow colostrum apart from other sources, appealing to individuals seeking a holistic health supplement.
The goat colostrum segment is anticipated to grow at a CAGR of 6.7% from 2024 to 2030. The increasing popularity of goat colostrum in infant formula applications is anticipated to drive segment expansion. Goat colostrum is a potent source of immunoglobulins, offering essential passive immunity to newborns and supporting immune system health in individuals of all ages. Moreover, it boasts elevated concentrations of protein, fat, vitamins, and minerals compared to regular milk, guaranteeing a robust foundation for the baby’s early growth and well-being.
The capsules segment accounted for the largest revenue share of 43.02% in 2023. Colostrum capsules offer a convenient and easily manageable way to consume colostrum, providing a precise dosage without the need for measuring powders or liquids. This convenience appeals to individuals seeking a hassle-free supplement regimen. For instance, NutriNoche's Colostrum Capsules provide a pure and potent source of colostrum, encapsulated for convenience and easy consumption. The chewable tablets segment is anticipated to grow at the fastest CAGR of 8.2% from 2024 to 2030.
Chewable tablets offer a pleasant and convenient way to consume colostrum, enhancing the overall palatability of the supplement. Factors, such as flavor variety, sweetness, and the absence of an undesirable aftertaste, contribute to the demand among consumers who seek enjoyable supplementation experiences. For instance, Kirkman Labs offers colostrum chewable tablets that contain pure colostrum sourced from bovine colostrum. These tablets provide immune support and digestive health benefits in a convenient and tasty format, meeting the demand for high-quality colostrum supplements.
The colostrum market in North America dominated with the revenue share of 33.74% in 2023 and is expected to grow at a CAGR of 7.4% from 2024 to 2030. Global manufacturers are targeting this region for expansion due to its large and growing market size, health-conscious consumer base, favorable regulatory environment, dominance of e-commerce platforms like Amazon, and the perceived quality and trust associated with products sourced from the region. For instance, in March 2024, BLACK SKULL, a brand under Grow Dietary Supplements Labs USA (GDS), a key brand in the hardcore nutrition segment in Brazil, presented its latest product at the Natural Products Expo West in Anaheim, California. It introduced its latest product, WHEY GRASS FED, with 19g of high-quality protein and 1g of Bovine Colostrum. This post-workout supplement is exclusively available on Amazon, initially targeting the North American market.
The U.S. colostrum market held a share of over 87.08% in 2023. Conditions, such as leaky gut syndrome, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), are increasingly prevalent in the U.S. Colostrum’s potential to support gastrointestinal health and promote gut barrier function makes it an attractive option for individuals seeking relief from digestive issues. According to data from the U.S. National Health and Nutrition Examination Survey (NHANES), 1% of the U.S. adult population (two million people) may have diagnosed IBD. This figure aligns with findings from previous nationally representative surveys in the U.S., indicating consistency in reported IBD prevalence across different studies.
The colostrum market in Asia Pacific held a revenue share of 31.00% in 2023. The large population of dairy cattle in the region has contributed to the significant production of colostrum. With a considerable number of dairy farms across countries like India, China, Australia, and New Zealand, APAC has emerged as a major supplier of colostrum globally. This abundance of colostrum has led to opportunities for innovation in colostrum-based products, including the manufacturing of new collagen products.
The Middle East & Africa colostrum market is expected to grow at a CAGR of 4.6% from 2024 to 2030. Companies in this regional market focus on educating consumers about the benefits of colostrum through various marketing and advertising strategies. They are also investing in R&D to create more affordable and innovative products that cater to the region’s specific needs and preferences.
The market is highly competitive, with a range of companies offering various forms. Many big players are increasing their focus on new form launches, partnerships, and expansion into new markets to compete effectively.
The following are the leading companies in the colostrum market. These companies collectively hold the largest market share and dictate industry trends.
In January 2024, Nuchev, a company specializing in infant products, expanded its offerings to include bovine products targeting immunity and digestion, inspired by consumer research in Australia and China. The new Oli6 Immunity + full cream milk powder contains colostrum, vitamins A and D, and lactoferrin to support immunity and overall health. The product is available in Australia and China through various distribution channels, with plans to explore in Southeast Asia
In April 2023, PanTheryx introduced a new product line tailored for healthcare practitioners, known as Life’s First Naturals PRO ColostrumOne Extra Strength. This innovative line is specifically crafted to bolster immune and digestive health in adults and children. The supplement is engineered using high-grade bovine colostrum and proprietary technology to enhance immune bioactives
Report Attribute |
Details |
Market form value in 2024 |
USD 3,577.1 million |
Revenue forecast in 2030 |
USD 5.43 billion |
Growth rate |
CAGR of 7.2% from 2024 to 2030 |
Actuals |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Nature, source, form, distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; Germany; UK; Spain; Italy; France; China; India; Japan; Australia & New Zealand; Brazil; South Africa |
Key companies profiled |
Glanbia PLC; Cure Nutraceutical Pvt. Ltd.; Colostrum BioTec GmbH; INGREDIA s.r.o.; Biotaris; NOW Foods; Agati Healthcare; Vivesa Holding s.r.o.; Zuche Pharmaceuticals; Deep Blue Health NZ |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global colostrum market report based on nature, source, form, distribution channel, and region:
Nature Outlook (Revenue, USD Million, 2018 - 2030)
Organic
Conventional
Source Outlook (Revenue, USD Million, 2018 - 2030)
Cow
Buffalo
Goat
Form Outlook (Revenue, USD Million, 2018 - 2030)
Powder
Whole Colostrum Powder
Skim Colostrum Powder
Specialty Colostrum Powder
Capsules
Chewable Tablets
Liquid
Stick
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
B2B
Functional Foods & Dietary Supplements
Animal Nutrition
Cosmetics
Infant Formula
Pharmaceuticals
B2C
Hypermarkets & Supermarkets
Convenience Stores
Online
Pharmacy & Drug Stores
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Asia Pacific
China
India
Japan
Australia & New Zealand
Central and South America
Brazil
Middle East & Africa
South Africa
b. The global colostrum market size was estimated at USD 3,362.7 million in 2023 and is expected to reach USD 3,577.1 million in 2024.
b. The global colostrum market is expected to grow at a compounded growth rate of 7.2% from 2024 to 2030 to reach USD 5,430.4 million by 2030.
b. The global colostrum market is expected to grow at a compounded growth rate of 7.2% from 2024 to 2030 to reach USD 5,430.4 million by 2030.
b. Some key players operating in the colostrum market are Glanbia PLC, Cure Nutraceutical Pvt. Ltd., Colostrum BioTec GmbH, INGREDIA s.r.o., Biotaris, NOW Foods, Agati Healthcare, Vivesa holding s.r.o., Zuche Pharmaceuticals, Deep Blue Health NZ.
b. There’s a rising interest in natural health solutions and alternative medicine among consumers. Colostrum aligns well with this trend, being a natural substance with a long history of traditional use for its purported health benefits. As people seek ways to support their immune systems and overall well-being, colostrum emerges as an attractive option due to its potential to enhance immune function, support gut health, and aid in tissue repair.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."